Tiger-One CBD 26:1 is a poly-hybrid medicinal strain with an average CBD:THC ratio of 26:1. It is a sativa-dominant plant.
This is a bushy plant whose branches develop a short inter-nodal length resulting in a plethora of budding sites. Indoors it reaches a height of 100 - 150 cm. tall producing a harvest of approximately 400 - 450 gr/m2 in 60 - 65 days of flowering following a 3 - 5 week vegetative growth phase.
Outdoors these plants grow to 180 - 250 cm. tall producing up to 1000 gr. per plant. The leaves are broad and can develop as many as eleven leaflets or fingers.
This strain's scent is heavy, sweet and fruity. THC production falls between 0.4 - 0.9% while CBD is an astonishing 12% - 22%. Recommended for medicinal usage.
Please note: the lab-test image refers to 26:1 CBD:THC ratio, that being the average proportion.
- Breeder/Brand Tiger One Bulk
- Product Type Seeds THC
- Variety Mostly Sativa
- Flowering Type Photoperiod
- Sex Feminised
- THC Content 0.4% - 0.9%
- CBD Content 12 - 22%
- Yield Indoors: 400 - 450 gr/m2; Outdoors: up to 1000 gr/plant
- Plant Height Indoors: 100 - 150 cm; Outdoors: 180 - 250 cm.
- Grows Greenhouse, Grows indoors, Grows outdoors
- Flowering Time 60 - 65 days
- Medicinal Properties Yes.
- Taste / Flavour Fruity, Sweet
- Effect Calming, Soothing
Strain FAQ
How does the prevalence of low THC strains reflect consumer trends?
Low THC strains are becoming more popular as cannabis society shifts from just seeking a high to respecting the abilities of the plant. This shows a more sophisticated view of cannabis, as users seek products with reported medicinal benefits without euphoric effects.
Can Sativa-dominant strains have high CBD?
Yes! Sativas are known for their THC and uplifting effects, but more and more Sativa dominant strains are being cultivated for their CBD content. These strains seek to produce calm and focus without a THC high.
Are there legal benefits to choosing low-THC cannabis in some regions?
Depending on where you find yourself on the map, the legal landscape might smile more favorably on cannabis's low-THC contingent. This legal leniency can make strains and products with less punch in the THC department more accessible in places where cannabis laws are rather draconian around THC content.
How will cannabis therapy evolve?
With so many strains and pharmacological characteristics, personalised cannabis treatment has a bright future. Patients and doctors will likely soon be able to choose strains that are said to target their ailments, enabling more personalised cannabis therapy.
Can CBD-rich strains be sweet?
Due to similar terpenes, CBD-rich strains might taste sweet like THC-dominant strains. It is not just about the cannabinoid profile here!